Table 2a Primary tumour models

From: Guidelines for the welfare and use of animals in cancer research

Model type

Examples of models

Advantages

Disadvantages

Chemically-induced tumours

Dimethyl hydrazine – gastric cancer (Watanabe et al, 1999)

Azoxymethane – colon cancer (Hirose et al, 2004)

Diethylnitrosamine – heptaocellular carcinoma (Ha et al, 2001)

Dimethyl benzanthracene – breast cancer (Hawariah and Stanslas, 1998)

N-acetylcysteine – squamous oesophageal carcinoma (Balansky et al, 2002)

Dimethylbenzanthracene/ tetradecanoyl phorbol acetate (TPA) – skin cancer (Johansen et al, 2009)

Model the full spectrum of carcinogenic events

Useful in chemoprevention studies

Low incidence and heterogeneous tumour development

Safety aspects associated with use of carcinogens – may need to house animals in isolator

Long time frame for tumour development

Continuous monitoring not feasible

Often highly immunogenic

Radiation-induced tumours

Ultraviolet light (Ahsan et al, 2005; De Fabo, 2006; El-Abaseri and Hansen, 2007)

Models non-melanoma (using UVA) and melanoma (UVB) skin cancer

Useful for prevention (e.g.. sunscreen) studies

Requires hairless mice

Inflammation-induced tumours

Helicobacter pylori-induced gastric cancer in gerbils (Zheng et al, 2004)

Use of conventional rodents to facilitate the involvement of the full spectrum of immune mediators

Models malignant progression and amenable for use of chemopreventive agents

Limited availability of models

Long time frame and variability in tumour development

Surgically-induced tumours

Oesophago-gastroduodenal anastomosis model of oesophageal carcinogenesis (Chen et al, 1999)

Can model malignant progression or metastatic spread

High level of skill required for initiation

Incidence may not be 100%

Accurate quantification can be difficult unless using real-time imaging

Spontaneous tumours, sometimes with viral/genetic component

T138 mice and mammary carcinoma (Wood et al, 1992; Nordsmark et al, 1996)

Cotton rats and neuroendocrine gastrointestinal tumours (Martinsen et al, 2003)

Eker rat model of tuberous sclerosis (Kenerson et al, 2005)

Develop cancer without any intervention

Conventional rodents, therefore fully immunocompetent

Limited tumour types and strains

Variability in the time frame of tumour development